Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) fell 1.7% during trading on Tuesday . The company traded as low as $2.23 and last traded at $2.25. 153,512 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,148,757 shares. The stock had previously closed at $2.29. Wall Street Analysts […]
StockNews.com began coverage on shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Get Rating) in a report published on Tuesday. The brokerage issued a sell rating on the stock. Separately, Mizuho reaffirmed a neutral rating and set a $3.50 price target on shares of Corvus Pharmaceuticals in a research report on Thursday, March 30th. Corvus Pharmaceuticals Stock […]